Human **DCX** Functional-Annotation Report Falcon Edison Scientific Literature 35 citations 1 artifacts 2026-09-27T16:28:54.778917

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Human DCX Functional-Annotation Report

Executive conclusion

The requested target is correctly identified: DCX encodes human neuronal migration protein doublecortin (UniProt O43602; aliases DBCN/LISX; 365 residues in the accession-linked experimental construct). It is a cytoplasmic, non-enzymatic microtubule-associated phosphoprotein, not the related kinase DCLK1. Both proteins contain doublecortin domains, but DCLK proteins additionally carry a C-terminal serine/threonine kinase domain; DCX does not. Human DCX contains two tandem, flexibly linked doublecortin domains—N-terminal NDC/DC1 and C-terminal CDC/DC2—followed by a serine/proline-rich regulatory tail. Thus, the supplied InterPro/Pfam assignments (DCX_chordates, Doublecortin domain/superfamily, PF03607) agree with the experimental literature. No conflicting same-symbol gene was identified. (reiner2006theevolvingdoublecortin pages 1-2, ramkumar2018remappingthemicrotubule pages 17-19, manka2020pseudo‐repeatsindoublecortin pages 1-2, rafiei2022doublecortinengagesthe pages 1-5)

Primary functional annotation: DCX is a structural regulator of neuronal microtubules. It promotes microtubule nucleation, favors the physiological 13-protofilament architecture, reinforces the microtubule lattice, and spatially coordinates microtubule and actin remodeling needed for neuronal migration, nucleokinesis, and neurite/growth-cone advance. It is neither an enzyme nor transporter, so there is no catalytic reaction or transported substrate to specify. Its principal molecular ligand is polymerizing or assembled α/β-tubulin, especially tubulin interfaces within nascent and mature microtubule lattices. (gleeson1999doublecortinisa pages 10-11, manka2020pseudo‐repeatsindoublecortin pages 11-13, manka2020pseudo‐repeatsindoublecortin pages 1-2, toriyama2012phosphorylationofdoublecortin pages 11-12)

Category Best-supported annotation Evidence type/strength Key caveat
Identity/domain architecture Human DCX (UniProt O43602) is a 365-residue doublecortin protein with tandem, flexibly linked N-terminal (NDC/DC1) and C-terminal (CDC/DC2) doublecortin domains followed by a serine/proline-rich tail. It is distinct from DCLK1, which additionally has a kinase domain. Strong: accession-linked recombinant human construct, comparative family analysis, structural studies Literature sometimes uses “DCX” for the protein, gene, domain family, or related proteins; organism and accession must therefore be checked.
Biochemical class Non-enzymatic, neuronal microtubule-associated phosphoprotein and cytoskeletal regulator; no catalytic reaction is known. Strong: biochemical coassembly, polymerization, microscopy, and structural evidence DCX has additional proposed transport and actin-related functions, but its primary established activity is microtubule regulation.
Substrate/ligand Binds assembled α/β-tubulin interfaces in microtubules—principally a corner formed by four tubulin dimers—and recognizes nascent tubulin assemblies; it is not established as binding free tubulin monomers with high affinity. Strong: cryo-EM, crosslinking, and reconstitution Domain occupancy and self-association models differ among structural studies; flexible regions remain difficult to resolve.
Microtubule nucleation Tandem DC domains promote nucleation and favor physiological 13-protofilament microtubules. The conformationally plastic CDC preferentially stabilizes curved/immature tubulin contacts during early assembly; tandem constructs nucleated at 5 µM tubulin, below the approximately 10 µM critical concentration. Strong: peer-reviewed cryo-EM and TIRF/reconstitution studies Isolated domains are insufficient; in-vitro tubulin and construct conditions may not reproduce neuronal post-translational modifications.
Mature-lattice stabilization NDC preferentially binds the mature, straighter GDP lattice, reinforces lateral and longitudinal contacts, reduces catastrophe/depolymerization, and tolerates 13- and 14-protofilament architectures. Strong: peer-reviewed structural and dynamic-assay evidence The proposed CDC-to-NDC transition is mechanistically persuasive but has not been visualized through its complete sequence in living neurons.
Cellular localization Cytoplasmic and microtubule-associated in newly postmitotic migrating/immature neurons; enriched on distal leading-process and growth-cone microtubules, with regulated association in proximal processes and the perinuclear region. Strong: neuronal immunolocalization, extraction, colocalization, and knockout studies Localization is fixation/extraction dependent, and a membrane-associated fraction has also been reported.
Phosphorylation/signaling PKA phosphorylation of Ser47 releases DCX from microtubules and links PACAP–Gs–PKA signaling to Asef2/Rac1-dependent lamellipodia and migration. MARK/PAR-1 also lowers microtubule affinity through the N-terminal regulatory region. CDK5 phosphorylation, principally at Ser297, reduces binding/polymerization and regulates perinuclear localization and migration. Moderate-to-strong: peer-reviewed kinase assays, phosphomutants, mass spectrometry, rescue, and migration experiments Some downstream actin interactions are model-based; Ser297 is a major rather than necessarily exclusive CDK5 site, and kinase effects are compartment dependent.
Biological process Organizes dynamic microtubules required for leading-process remodeling, nucleokinesis, neuronal migration, cortical lamination, neurite/axon growth, and neuronal maturation. It may also influence kinesin-dependent cargo transport. Strong for migration and microtubules; moderate for transport and actin coupling Single-gene animal phenotypes can be buffered by DCLK-family redundancy, complicating extrapolation to human loss of function.
Disease Pathogenic DCX variants cause an X-linked lissencephaly spectrum: hemizygous males usually develop lissencephaly, whereas heterozygous females commonly develop subcortical band heterotopia (“double cortex”), epilepsy, and variable intellectual disability. Mosaicism and X-inactivation modify severity. Strong: human genetics, characteristic MRI phenotypes, segregation, functional studies, and expert consensus Genotype–phenotype prediction remains imperfect; mildly affected or asymptomatic female carriers can be missed.
Current applications DCX immunostaining/transcript detection is widely used as a research marker of migrating neuroblasts and immature neurons; DCX sequencing is implemented in diagnostic evaluation and family counselling for compatible cortical malformations. Cancer and injury biomarker uses remain investigational. Established research and genetic-diagnostic use; observational evidence for biomarkers DCX positivity is not synonymous with cell division or definitive adult neurogenesis, and no DCX-directed therapy is established.
2023–2024 emerging findings A 2023 human iPSC-neuron preprint linked DCX knockout to slower, less directional nuclear movement, approximately twofold higher net neurite formation, reduced tubulin polyglutamylation, and impaired lysosome processivity despite largely unchanged EB3 dynamics. 2023–2024 clinical reports expanded variant and phenotypic spectra, including marked intrafamilial variability. Emerging: preprint mechanistic work plus peer-reviewed small clinical series Tubulin-code causality is not yet established, the cellular work was not peer reviewed in the retrieved evidence, and clinical series are small rather than population based.

Table: Compact evidence-based annotation of human doublecortin, separating established molecular and clinical functions from emerging preprint and observational findings.

1. Molecular function and mechanism

1.1 Microtubule nucleation and architecture

Early biochemical work showed that DCX colocalizes and coassembles with microtubules, promotes polymerization and bundling, and renders a fraction of microtubules resistant to colchicine and cold-induced depolymerization. These observations established DCX as a bona fide neuronal MAP rather than merely an expression marker. (gleeson1999doublecortinisa pages 10-11)

Modern cryo-EM and TIRF studies refine that description into a domain-specialized mechanism. A DC domain binds near a corner formed by four α/β-tubulin dimers, reinforcing both longitudinal and lateral lattice contacts. The conformationally plastic CDC/DC2 domain preferentially recognizes curved tubulin oligomers or immature GTP/GDP·Pi-like lattice states, stabilizing tubulin–tubulin contacts during nucleation and lattice closure. The more rigid NDC/DC1 domain preferentially occupies the straighter mature GDP lattice and provides durable stabilization against depolymerization. NDC forms approximately 11 ionic interactions, compared with 9 for CDC, consistent with stronger mature-lattice engagement. (manka2020pseudo‐repeatsindoublecortin pages 11-13, manka2020pseudo‐repeatsindoublecortin pages 7-9)

The tandem arrangement is functionally important: isolated domains did not stimulate polymerization under tested conditions, whereas tandem constructs nucleated microtubules at 5 μM tubulin, below the approximately 10 μM critical concentration. DCX strongly favors 13-protofilament microtubules; NDC can nevertheless accommodate both 13- and 14-protofilament lattices. These results support a sequential model—CDC assists assembly, then NDC stabilizes the mature polymer—rather than two interchangeable repeats. (manka2020pseudo‐repeatsindoublecortin pages 7-9, manka2020pseudo‐repeatsindoublecortin pages 1-2)

An integrative structural model adds that NDC supplies the principal lattice anchor while CDC and the C-terminal tail support cooperative DCX self-association. Reported microtubule binding had a Hill coefficient approaching 3, and recombinant effects saturated at roughly 10–20 μM DCX with an approximately 1:1 DCX:α/β-tubulin stoichiometry. However, flexible-domain occupancy and self-association remain less certain than the core conclusion that tandem DC domains nucleate and stabilize microtubules. (rafiei2022doublecortinengagesthe pages 16-20, rafiei2022doublecortinengagesthe pages 5-9, rafiei2022doublecortinengagesthe pages 1-5)

1.2 Cellular consequence

Migrating neurons repeatedly extend a leading process and move the centrosome and nucleus forward. DCX-stabilized microtubules provide a sufficiently coherent yet remodelable scaffold for this saltatory nucleokinesis, leading-process dynamics, cortical radial migration, and lamination. DCX also contributes to growth-cone formation, axon/neurite extension and dendritic development. Interaction of DCX-family proteins with kinesin-3 motors KIF1A/KIF1C and trafficking defects after DCX loss suggest a secondary role in cargo transport along neuronal microtubules. (ayanlaja2017distinctfeaturesof pages 1-2, gleeson1999doublecortinisa pages 10-11, ramkumar2018remappingthemicrotubule pages 17-19)

2. Localization and expression

DCX is most strongly expressed in newly postmitotic, migrating and immature neurons during embryonic and early postnatal nervous-system development; expression generally falls as neurons terminally differentiate. It is therefore widely used as a marker of migrating neuroblasts and neuronal maturation, although DCX positivity alone does not prove cell division or fully establish adult neurogenesis. (ayanlaja2017distinctfeaturesof pages 1-2, gleeson1999doublecortinisa pages 10-11, ramkumar2018remappingthemicrotubule pages 17-19)

Within cells, DCX is cytoplasmic and microtubule-associated rather than secreted or membrane-spanning. It is enriched on distal microtubules near neurite growth cones and the leading edge of migrating neurons, where microtubule guidance and remodeling are most active. Other experiments identify DCX on thick proximal-process bundles and thin perinuclear microtubules. Apparent somatic versus process localization varies with fixation and extraction, and a membrane-associated fraction has also been observed. The best interpretation is consequently a dynamic, compartment-regulated microtubule association, not a fixed residence in one organelle. (ayanlaja2017distinctfeaturesof pages 8-9, schaar2004doublecortinmicrotubuleaffinity pages 2-3, tanaka2004cdk5phosphorylationof pages 4-5, schaar2004doublecortinmicrotubuleaffinity pages 6-7)

3. Signaling and biochemical regulation

DCX is a phosphoprotein whose microtubule affinity is tuned by extracellular and intracellular signaling.

Collectively, these results show that DCX is not simply a constitutive microtubule “glue.” Kinase/phosphatase gradients locally switch DCX between microtubule-bound stabilization and cytoskeletal-remodeling states.

4. Human disease mechanism and recent clinical evidence

Pathogenic variants cause the X-linked lissencephaly spectrum. Hemizygous males usually develop classical lissencephaly, with a thick, abnormally smooth cortex, severe developmental impairment and epilepsy. Heterozygous females more often develop subcortical band heterotopia (SBH; “double cortex”), in which a smooth, bilateral band of heterotopic gray matter lies within subcortical white matter. Random or skewed X-inactivation makes females cellular mosaics, while somatic mosaicism can produce milder or atypical disease in either sex. (edey2023x‐linkedneuronalmigration pages 3-4, edey2023x‐linkedneuronalmigration pages 2-3, edey2023x‐linkedneuronalmigration pages 2-2)

A 2023 review reported DCX variants in 322/483 (67%) studied SBH patients, 65% of SBH patients having refractory epilepsy, and familial cases comprising approximately one third—probably an underestimate because mildly affected women can escape diagnosis. The same review identified 14 asymptomatic female carriers with imaging-defined SBH in one cited series. DCX and PAFAH1B1/LIS1 together account for up to 76% of lissencephaly in cited cohorts. These figures derive from selected published cohorts rather than population prevalence studies. (edey2023x‐linkedneuronalmigration pages 3-4, edey2023x‐linkedneuronalmigration pages 2-2, edey2023x‐linkedneuronalmigration pages 4-4)

Variant consequences generally fit the molecular mechanism: truncating/deletion/frameshift alleles tend to be more severe, while some missense substitutions retain partial function; variants disrupting DC-domain folding, tubulin-contact surfaces or CDC conformational plasticity impair microtubule regulation. Nevertheless, position alone cannot reliably predict phenotype because X-inactivation, mosaicism and genetic background are important modifiers. (manka2020pseudo‐repeatsindoublecortin pages 7-9, edey2023x‐linkedneuronalmigration pages 2-3, edey2023x‐linkedneuronalmigration pages 4-4)

A 2024 three-family study illustrates this variability. Four generations carrying p.Lys201Glu showed fronto-central SBH/pachygyria ranging from unaffected carriers to focal epilepsy and IQ values of 60–64. Two unrelated women with p.Tyr70 or p.Arg303** had severe drug-resistant epilepsy, intellectual disability and bilateral pachygyria/SBH. These are informative cases, not incidence estimates. Published May 2024, DOI/URL: https://doi.org/10.3390/ijms25105505. (procopio2024phenotypicvariabilityin pages 2-4)

5. Recent research, 2023–2024

A 2023 human iPSC-neuron CRISPR study proposed that DCX also “edits” the tubulin code. DCX-knockout neurons showed slower, less directional nuclear movement, an approximately twofold increase in net neurite formation, reduced tubulin polyglutamylation and reduced lysosome processivity. Conventional plus-end dynamics were largely unchanged: EB3-comet density was 0.40 ± 0.04 versus 0.44 ± 0.04 μm⁻², velocity 10.51 ± 0.34 versus 9.97 ± 0.38 μm/min, and lifetime 13.08 ± 0.46 versus 12.46 ± 0.57 s. This suggests that DCX loss may alter microtubule chemical identity and motor traffic without globally changing growth rates. However, the retrieved article was a preprint, and direct causality between DCX, polyglutamylation, transport and migration remains to be established. (sebastien2023doublecortinregulatesneuronal pages 1-3, sebastien2023doublecortinregulatesneuronal pages 5-6)

Recent clinical work has focused less on a new biochemical function and more on variant interpretation, mosaicism and family screening. The 2023 expert review recommends testing relatives after an SBH diagnosis because an asymptomatic or mildly affected mother can transmit a variant to a son with severe lissencephaly. The 2024 family study reinforces that even the same variant can yield markedly different epilepsy, cognitive and imaging phenotypes. (edey2023x‐linkedneuronalmigration pages 4-4, procopio2024phenotypicvariabilityin pages 2-4)

6. Current applications and translational status

  1. Clinical genetic diagnosis: DCX sequencing or inclusion in malformation-of-cortical-development/epilepsy panels is an established application when MRI shows anterior/frontally predominant lissencephaly or bilateral SBH. Results support recurrence-risk assessment, testing of apparently unaffected female relatives and prenatal counselling. MRI remains important, but genetic confirmation is needed because mosaicism and overlapping genes complicate diagnosis. (edey2023x‐linkedneuronalmigration pages 2-3, edey2023x‐linkedneuronalmigration pages 2-2, edey2023x‐linkedneuronalmigration pages 4-4, procopio2024phenotypicvariabilityin pages 2-4)
  2. Research histology: DCX immunostaining and transcript detection are standard tools for identifying migrating neuroblasts and immature/maturing neurons in developmental, injury and neurogenesis studies. Interpretation must remain stage- and species-aware; DCX is a differentiation/maturation marker, not a stand-alone demonstration that adult neurons were newly generated. (ayanlaja2017distinctfeaturesof pages 1-2, gleeson1999doublecortinisa pages 10-11, deoliveiramello2022doublecortininthe pages 12-12)
  3. Experimental disease modeling: Patient-derived or CRISPR-edited neural cells and organoid-type systems use DCX expression, localization and migration phenotypes to study cortical malformations and test variant function. The 2023 iPSC work exemplifies how these systems can separate lattice dynamics from tubulin-modification and cargo-transport effects. (sebastien2023doublecortinregulatesneuronal pages 1-3, sebastien2023doublecortinregulatesneuronal pages 5-6)
  4. Investigational biomarkers: DCX RNA in marrow or blood has been explored as a neuroblastoma minimal-residual-disease marker; high marrow DCX was associated with poorer event-free and overall survival in a selected cohort. DCX expression has also been investigated in cancer and neural injury, but these are observational applications and are not equivalent to a validated DCX-directed diagnostic or therapy. (ayanlaja2017distinctfeaturesof pages 8-9)

No established drug directly targets DCX, and no evidence retrieved supports DCX replacement, kinase modulation or tubulin-code manipulation as current clinical treatment. Clinical management remains directed at diagnosis, counselling, seizures, developmental complications and the underlying cortical malformation.

7. Expert assessment and remaining uncertainties

The most secure annotation is “neuronal microtubule nucleator and lattice-stabilizing MAP required for migration.” Convergent human genetics, cell biology, reconstitution and near-atomic structural data support this assignment. The strongest mechanistic advance is recognition that the two homologous DC domains are not redundant: CDC chaperones early/curved tubulin assemblies, whereas NDC stabilizes the mature lattice. (manka2020pseudo‐repeatsindoublecortin pages 11-13, manka2020pseudo‐repeatsindoublecortin pages 7-9, manka2020pseudo‐repeatsindoublecortin pages 1-2)

Important open questions are how the CDC-to-NDC transition occurs in living neurons; how DCX self-association, phosphorylation and tubulin post-translational modifications interact; whether trafficking effects are primary or secondary to altered lattice organization; and how DCLK-family compensation changes phenotypes across cell types. The proposed tubulin-polyglutamylation mechanism is promising but remains emerging, and cancer biomarker associations should not be interpreted as demonstrating that neuronal DCX is an established oncogenic driver. (ayanlaja2017distinctfeaturesof pages 8-9, sebastien2023doublecortinregulatesneuronal pages 1-3, rafiei2022doublecortinengagesthe pages 16-20, rafiei2022doublecortinengagesthe pages 1-5)

References

  1. (reiner2006theevolvingdoublecortin pages 1-2): Orly Reiner, Frédéric M Coquelle, Bastian Peter, Talia Levy, Anna Kaplan, Tamar Sapir, Irit Orr, Naama Barkai, Gregor Eichele, and Sven Bergmann. The evolving doublecortin (dcx) superfamily. BMC Genomics, 7:188-188, Jul 2006. URL: https://doi.org/10.1186/1471-2164-7-188, doi:10.1186/1471-2164-7-188. This article has 156 citations and is from a peer-reviewed journal.

  2. (ramkumar2018remappingthemicrotubule pages 17-19): Amrita Ramkumar, Brigette Y. Jong, and Kassandra M. Ori‐McKenney. Remapping the microtubule landscape: how phosphorylation dictates the activities of microtubule‐associated proteins. Developmental Dynamics, 247:138-155, Jan 2018. URL: https://doi.org/10.1002/dvdy.24599, doi:10.1002/dvdy.24599. This article has 242 citations and is from a peer-reviewed journal.

  3. (manka2020pseudo‐repeatsindoublecortin pages 1-2): Szymon W Manka and Carolyn A Moores. Pseudo‐repeats in doublecortin make distinct mechanistic contributions to microtubule regulation. EMBO reports, Oct 2020. URL: https://doi.org/10.15252/embr.202051534, doi:10.15252/embr.202051534. This article has 48 citations and is from a highest quality peer-reviewed journal.

  4. (rafiei2022doublecortinengagesthe pages 1-5): Atefeh Rafiei, Sofia Cruz Tetlalmatzi, Claire H. Edrington, Linda Lee, D. Crowder, Daniel J. Saltzberg, A. Sali, G. Brouhard, and D. Schriemer. Doublecortin engages the microtubule lattice through a cooperative binding mode involving its c-terminal domain. BioRxiv, Feb 2022. URL: https://doi.org/10.1101/2021.02.17.431714, doi:10.1101/2021.02.17.431714. This article has 17 citations.

  5. (gleeson1999doublecortinisa pages 10-11): Joseph G Gleeson, Peter T Lin, Lisa A Flanagan, and Christopher A Walsh. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron, 23:257-271, Jun 1999. URL: https://doi.org/10.1016/s0896-6273(00)80778-3, doi:10.1016/s0896-6273(00)80778-3. This article has 1696 citations and is from a highest quality peer-reviewed journal.

  6. (manka2020pseudo‐repeatsindoublecortin pages 11-13): Szymon W Manka and Carolyn A Moores. Pseudo‐repeats in doublecortin make distinct mechanistic contributions to microtubule regulation. EMBO reports, Oct 2020. URL: https://doi.org/10.15252/embr.202051534, doi:10.15252/embr.202051534. This article has 48 citations and is from a highest quality peer-reviewed journal.

  7. (toriyama2012phosphorylationofdoublecortin pages 11-12): Manami Toriyama, Norikazu Mizuno, Takashi Fukami, Tokuichi Iguchi, Michinori Toriyama, Kenji Tago, and Hiroshi Itoh. Phosphorylation of doublecortin by protein kinase a orchestrates microtubule and actin dynamics to promote neuronal progenitor cell migration. Apr 2012. URL: https://doi.org/10.1074/jbc.m111.316307, doi:10.1074/jbc.m111.316307. This article has 57 citations and is from a domain leading peer-reviewed journal.

  8. (manka2020pseudo‐repeatsindoublecortin pages 7-9): Szymon W Manka and Carolyn A Moores. Pseudo‐repeats in doublecortin make distinct mechanistic contributions to microtubule regulation. EMBO reports, Oct 2020. URL: https://doi.org/10.15252/embr.202051534, doi:10.15252/embr.202051534. This article has 48 citations and is from a highest quality peer-reviewed journal.

  9. (rafiei2022doublecortinengagesthe pages 16-20): Atefeh Rafiei, Sofia Cruz Tetlalmatzi, Claire H. Edrington, Linda Lee, D. Crowder, Daniel J. Saltzberg, A. Sali, G. Brouhard, and D. Schriemer. Doublecortin engages the microtubule lattice through a cooperative binding mode involving its c-terminal domain. BioRxiv, Feb 2022. URL: https://doi.org/10.1101/2021.02.17.431714, doi:10.1101/2021.02.17.431714. This article has 17 citations.

  10. (rafiei2022doublecortinengagesthe pages 5-9): Atefeh Rafiei, Sofia Cruz Tetlalmatzi, Claire H. Edrington, Linda Lee, D. Crowder, Daniel J. Saltzberg, A. Sali, G. Brouhard, and D. Schriemer. Doublecortin engages the microtubule lattice through a cooperative binding mode involving its c-terminal domain. BioRxiv, Feb 2022. URL: https://doi.org/10.1101/2021.02.17.431714, doi:10.1101/2021.02.17.431714. This article has 17 citations.

  11. (ayanlaja2017distinctfeaturesof pages 1-2): Abiola A. Ayanlaja, Ye Xiong, Yue Gao, GuangQuan Ji, Chuanxi Tang, Zamzam Abdikani Abdullah, and DianShuai Gao. Distinct features of doublecortin as a marker of neuronal migration and its implications in cancer cell mobility. Frontiers in Molecular Neuroscience, Jun 2017. URL: https://doi.org/10.3389/fnmol.2017.00199, doi:10.3389/fnmol.2017.00199. This article has 194 citations.

  12. (ayanlaja2017distinctfeaturesof pages 8-9): Abiola A. Ayanlaja, Ye Xiong, Yue Gao, GuangQuan Ji, Chuanxi Tang, Zamzam Abdikani Abdullah, and DianShuai Gao. Distinct features of doublecortin as a marker of neuronal migration and its implications in cancer cell mobility. Frontiers in Molecular Neuroscience, Jun 2017. URL: https://doi.org/10.3389/fnmol.2017.00199, doi:10.3389/fnmol.2017.00199. This article has 194 citations.

  13. (schaar2004doublecortinmicrotubuleaffinity pages 2-3): Bruce T Schaar, Kazuhisa Kinoshita, and Susan K McConnell. Doublecortin microtubule affinity is regulated by a balance of kinase and phosphatase activity at the leading edge of migrating neurons. Neuron, 41:203-213, Jan 2004. URL: https://doi.org/10.1016/s0896-6273(03)00843-2, doi:10.1016/s0896-6273(03)00843-2. This article has 255 citations and is from a highest quality peer-reviewed journal.

  14. (tanaka2004cdk5phosphorylationof pages 4-5): Teruyuki Tanaka, Finley F. Serneo, Huang-Chun Tseng, Ashok B. Kulkarni, Li-Huei Tsai, and Joseph G. Gleeson. Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration. Neuron, 41:215-227, Jan 2004. URL: https://doi.org/10.1016/s0896-6273(03)00852-3, doi:10.1016/s0896-6273(03)00852-3. This article has 318 citations and is from a highest quality peer-reviewed journal.

  15. (schaar2004doublecortinmicrotubuleaffinity pages 6-7): Bruce T Schaar, Kazuhisa Kinoshita, and Susan K McConnell. Doublecortin microtubule affinity is regulated by a balance of kinase and phosphatase activity at the leading edge of migrating neurons. Neuron, 41:203-213, Jan 2004. URL: https://doi.org/10.1016/s0896-6273(03)00843-2, doi:10.1016/s0896-6273(03)00843-2. This article has 255 citations and is from a highest quality peer-reviewed journal.

  16. (toriyama2012phosphorylationofdoublecortin pages 1-2): Manami Toriyama, Norikazu Mizuno, Takashi Fukami, Tokuichi Iguchi, Michinori Toriyama, Kenji Tago, and Hiroshi Itoh. Phosphorylation of doublecortin by protein kinase a orchestrates microtubule and actin dynamics to promote neuronal progenitor cell migration. Apr 2012. URL: https://doi.org/10.1074/jbc.m111.316307, doi:10.1074/jbc.m111.316307. This article has 57 citations and is from a domain leading peer-reviewed journal.

  17. (toriyama2012phosphorylationofdoublecortin pages 4-5): Manami Toriyama, Norikazu Mizuno, Takashi Fukami, Tokuichi Iguchi, Michinori Toriyama, Kenji Tago, and Hiroshi Itoh. Phosphorylation of doublecortin by protein kinase a orchestrates microtubule and actin dynamics to promote neuronal progenitor cell migration. Apr 2012. URL: https://doi.org/10.1074/jbc.m111.316307, doi:10.1074/jbc.m111.316307. This article has 57 citations and is from a domain leading peer-reviewed journal.

  18. (schaar2004doublecortinmicrotubuleaffinity pages 1-2): Bruce T Schaar, Kazuhisa Kinoshita, and Susan K McConnell. Doublecortin microtubule affinity is regulated by a balance of kinase and phosphatase activity at the leading edge of migrating neurons. Neuron, 41:203-213, Jan 2004. URL: https://doi.org/10.1016/s0896-6273(03)00843-2, doi:10.1016/s0896-6273(03)00843-2. This article has 255 citations and is from a highest quality peer-reviewed journal.

  19. (tanaka2004cdk5phosphorylationof pages 1-2): Teruyuki Tanaka, Finley F. Serneo, Huang-Chun Tseng, Ashok B. Kulkarni, Li-Huei Tsai, and Joseph G. Gleeson. Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration. Neuron, 41:215-227, Jan 2004. URL: https://doi.org/10.1016/s0896-6273(03)00852-3, doi:10.1016/s0896-6273(03)00852-3. This article has 318 citations and is from a highest quality peer-reviewed journal.

  20. (edey2023x‐linkedneuronalmigration pages 3-4): Juliet Edey, Payam Soleimani‐Nouri, Amelia Dawson‐Kavanagh, Muhamad Saad Imran Azeem, and Vasso Episkopou. X‐linked neuronal migration disorders: gender differences and insights for genetic screening. International Journal of Developmental Neuroscience, 83:581-599, Aug 2023. URL: https://doi.org/10.1002/jdn.10290, doi:10.1002/jdn.10290. This article has 11 citations and is from a peer-reviewed journal.

  21. (edey2023x‐linkedneuronalmigration pages 2-3): Juliet Edey, Payam Soleimani‐Nouri, Amelia Dawson‐Kavanagh, Muhamad Saad Imran Azeem, and Vasso Episkopou. X‐linked neuronal migration disorders: gender differences and insights for genetic screening. International Journal of Developmental Neuroscience, 83:581-599, Aug 2023. URL: https://doi.org/10.1002/jdn.10290, doi:10.1002/jdn.10290. This article has 11 citations and is from a peer-reviewed journal.

  22. (edey2023x‐linkedneuronalmigration pages 2-2): Juliet Edey, Payam Soleimani‐Nouri, Amelia Dawson‐Kavanagh, Muhamad Saad Imran Azeem, and Vasso Episkopou. X‐linked neuronal migration disorders: gender differences and insights for genetic screening. International Journal of Developmental Neuroscience, 83:581-599, Aug 2023. URL: https://doi.org/10.1002/jdn.10290, doi:10.1002/jdn.10290. This article has 11 citations and is from a peer-reviewed journal.

  23. (edey2023x‐linkedneuronalmigration pages 4-4): Juliet Edey, Payam Soleimani‐Nouri, Amelia Dawson‐Kavanagh, Muhamad Saad Imran Azeem, and Vasso Episkopou. X‐linked neuronal migration disorders: gender differences and insights for genetic screening. International Journal of Developmental Neuroscience, 83:581-599, Aug 2023. URL: https://doi.org/10.1002/jdn.10290, doi:10.1002/jdn.10290. This article has 11 citations and is from a peer-reviewed journal.

  24. (procopio2024phenotypicvariabilityin pages 2-4): Radha Procopio, Francesco Fortunato, Monica Gagliardi, Mariagrazia Talarico, Ilaria Sammarra, Maria Chiara Sarubbi, Donatella Malanga, Grazia Annesi, and Antonio Gambardella. Phenotypic variability in novel doublecortin gene variants associated with subcortical band heterotopia. May 2024. URL: https://doi.org/10.3390/ijms25105505, doi:10.3390/ijms25105505. This article has 10 citations.

  25. (sebastien2023doublecortinregulatesneuronal pages 1-3): M Sébastien, ENP Prowse, and AG Hendricks. Doublecortin regulates neuronal migration by editing the tubulin code. Unknown journal, 2023.

  26. (sebastien2023doublecortinregulatesneuronal pages 5-6): M Sébastien, ENP Prowse, and AG Hendricks. Doublecortin regulates neuronal migration by editing the tubulin code. Unknown journal, 2023.

  27. (deoliveiramello2022doublecortininthe pages 12-12): Laura DeOliveira-Mello, Isabel Vicente, Veronica Gonzalez-Nunez, Adrian Santos-Ledo, Almudena Velasco, Rosario Arévalo, Juan M. Lara, and Andreas F. Mack. Doublecortin in the fish visual system, a specific protein of maturing neurons. Biology, 11:248, Feb 2022. URL: https://doi.org/10.3390/biology11020248, doi:10.3390/biology11020248. This article has 2 citations.

Artifacts

Citations

  1. gleeson1999doublecortinisa pages 10-11
  2. procopio2024phenotypicvariabilityin pages 2-4
  3. ayanlaja2017distinctfeaturesof pages 8-9
  4. schaar2004doublecortinmicrotubuleaffinity pages 2-3
  5. toriyama2012phosphorylationofdoublecortin pages 1-2
  6. reiner2006theevolvingdoublecortin pages 1-2
  7. ramkumar2018remappingthemicrotubule pages 17-19
  8. rafiei2022doublecortinengagesthe pages 1-5
  9. toriyama2012phosphorylationofdoublecortin pages 11-12
  10. rafiei2022doublecortinengagesthe pages 16-20
  11. rafiei2022doublecortinengagesthe pages 5-9
  12. ayanlaja2017distinctfeaturesof pages 1-2
  13. schaar2004doublecortinmicrotubuleaffinity pages 6-7
  14. toriyama2012phosphorylationofdoublecortin pages 4-5
  15. schaar2004doublecortinmicrotubuleaffinity pages 1-2
  16. sebastien2023doublecortinregulatesneuronal pages 1-3
  17. sebastien2023doublecortinregulatesneuronal pages 5-6
  18. deoliveiramello2022doublecortininthe pages 12-12
  19. https://doi.org/10.3390/ijms25105505.
  20. https://doi.org/10.1016/S0896-6273(00
  21. https://doi.org/10.1016/S0896-6273(03
  22. https://doi.org/10.1074/jbc.M111.316307.
  23. https://doi.org/10.15252/embr.202051534.
  24. https://doi.org/10.1002/jdn.10290.
  25. https://doi.org/10.1186/1471-2164-7-188,
  26. https://doi.org/10.1002/dvdy.24599,
  27. https://doi.org/10.15252/embr.202051534,
  28. https://doi.org/10.1101/2021.02.17.431714,
  29. https://doi.org/10.1016/s0896-6273(00
  30. https://doi.org/10.1074/jbc.m111.316307,
  31. https://doi.org/10.3389/fnmol.2017.00199,
  32. https://doi.org/10.1016/s0896-6273(03
  33. https://doi.org/10.1002/jdn.10290,
  34. https://doi.org/10.3390/ijms25105505,
  35. https://doi.org/10.3390/biology11020248,